Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysisMark A Jenkins, James G Dowty, Driss Ait Ouakrim, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2024
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulationAlison Antoine, David Pérol, Mathieu Robain, et al.
Scientific Reports|May 11, 2018
Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancerYouenn Drouet, Isabelle Treilleux, Alain Viari, et al.
EMBO Molecular Medicine|July 17, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα<sup>+</sup> breast cancerCoralie Poulard, Thuy Ha Pham, Youenn Drouet, et al.
Breast Cancer Research : BCR|June 10, 2026
Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohortStéphane Vignot, Youenn Drouet, Antonio Di Meglio, et al.
Gastroenterology|September 7, 2011
Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancerMarie-May Coissieux, Jerneja Tomsic, Marie Castets, et al.
Cancer Research Communications|September 14, 2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersBoris Guyot, Flora Clément, Youenn Drouet, et al.
European Journal of Human Genetics : EJHG|May 13, 2026
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
Blood Cancer Journal|January 9, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapyHervé Ghesquières, Youenn Drouet, Susan L Slager, et al.
European Journal of Human Genetics : EJHG|October 3, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriersMarie-Charlotte Villy, Youenn Drouet, Lise Larcher, et al.
Pageof 3